Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bipolar Hemostatic Forceps Versus Standard Therapy by Hemoclip and or Epinephrin Injection as Initial Endoscopic Treatment in Acute Non-variceal Upper GI Bleeding: a Prospective, Randomized Multicenter Study

NCT05353062 is registered in ClinicalTrials.gov with Theresienkrankenhaus und St. Hedwig-Klinik GmbH as lead sponsor.

NCT NCT05353062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05353062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bipolar Hemostatic Forceps Versus Standard Therapy by Hemoclip and or Epinephrin Injection as Initial Endoscopic Treatment in Acute Non-variceal Upper GI Bleeding: a Prospective, Randomized Multicenter Study
Lead sponsor
Theresienkrankenhaus und St. Hedwig-Klinik GmbH
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2023
Completion date
February 1, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal hemorrhage